324 related articles for article (PubMed ID: 32308554)
1. Resolution of Inflammation in Neurodegenerative Diseases: The Role of Resolvins.
Chamani S; Bianconi V; Tasbandi A; Pirro M; Barreto GE; Jamialahmadi T; Sahebkar A
Mediators Inflamm; 2020; 2020():3267172. PubMed ID: 32308554
[TBL] [Abstract][Full Text] [Related]
2. Omega-3 fatty acids and their lipid mediators: towards an understanding of resolvin and protectin formation.
Weylandt KH; Chiu CY; Gomolka B; Waechter SF; Wiedenmann B
Prostaglandins Other Lipid Mediat; 2012 Mar; 97(3-4):73-82. PubMed ID: 22326554
[TBL] [Abstract][Full Text] [Related]
3. Resolvins Lipid Mediators: Potential Therapeutic Targets in Alzheimer and Parkinson Disease.
Anand S; Azam Ansari M; Kumaraswamy Sukrutha S; Alomary MN; Anwar Khan A; Elderdery AY
Neuroscience; 2022 Dec; 507():139-148. PubMed ID: 36372297
[TBL] [Abstract][Full Text] [Related]
4. Emerging roles of resolvins in the resolution of inflammation and pain.
Ji RR; Xu ZZ; Strichartz G; Serhan CN
Trends Neurosci; 2011 Nov; 34(11):599-609. PubMed ID: 21963090
[TBL] [Abstract][Full Text] [Related]
5. E-series resolvin metabolome, biosynthesis and critical role of stereochemistry of specialized pro-resolving mediators (SPMs) in inflammation-resolution: Preparing SPMs for long COVID-19, human clinical trials, and targeted precision nutrition.
Serhan CN; Libreros S; Nshimiyimana R
Semin Immunol; 2022 Jan; 59():101597. PubMed ID: 35227568
[TBL] [Abstract][Full Text] [Related]
6. Cell-cell interaction in the transcellular biosynthesis of novel omega-3-derived lipid mediators.
Chiang N; Serhan CN
Methods Mol Biol; 2006; 341():227-50. PubMed ID: 16799203
[TBL] [Abstract][Full Text] [Related]
7. Resolvins, docosatrienes, and neuroprotectins, novel omega-3-derived mediators, and their endogenous aspirin-triggered epimers.
Serhan CN; Arita M; Hong S; Gotlinger K
Lipids; 2004 Nov; 39(11):1125-32. PubMed ID: 15726828
[TBL] [Abstract][Full Text] [Related]
8. EPA- and DHA-derived resolvins' actions in inflammatory bowel disease.
Schwanke RC; Marcon R; Bento AF; Calixto JB
Eur J Pharmacol; 2016 Aug; 785():156-164. PubMed ID: 26325092
[TBL] [Abstract][Full Text] [Related]
9. Identification of inflammatory and proresolving lipid mediators in bone marrow and their lipidomic profiles with ovariectomy and omega-3 intake.
Poulsen RC; Gotlinger KH; Serhan CN; Kruger MC
Am J Hematol; 2008 Jun; 83(6):437-45. PubMed ID: 18429055
[TBL] [Abstract][Full Text] [Related]
10. Resolvins, docosatrienes, and neuroprotectins, novel omega-3-derived mediators, and their aspirin-triggered endogenous epimers: an overview of their protective roles in catabasis.
Serhan CN; Gotlinger K; Hong S; Arita M
Prostaglandins Other Lipid Mediat; 2004 Apr; 73(3-4):155-72. PubMed ID: 15290791
[TBL] [Abstract][Full Text] [Related]
11. Pro-resolving mediators produced from EPA and DHA: Overview of the pathways involved and their mechanisms in metabolic syndrome and related liver diseases.
López-Vicario C; Rius B; Alcaraz-Quiles J; García-Alonso V; Lopategi A; Titos E; Clària J
Eur J Pharmacol; 2016 Aug; 785():133-143. PubMed ID: 25987424
[TBL] [Abstract][Full Text] [Related]
12. Implications for eicosapentaenoic acid- and docosahexaenoic acid-derived resolvins as therapeutics for arthritis.
Souza PR; Norling LV
Eur J Pharmacol; 2016 Aug; 785():165-173. PubMed ID: 26165764
[TBL] [Abstract][Full Text] [Related]
13. [Anti-inflammatory pro-resolving derivatives of omega-3 and omega-6 polyunsaturated fatty acids].
Nowak JZ
Postepy Hig Med Dosw (Online); 2010 Mar; 64():115-32. PubMed ID: 20354260
[TBL] [Abstract][Full Text] [Related]
14. Resolvins: anti-inflammatory and proresolving mediators derived from omega-3 polyunsaturated fatty acids.
Zhang MJ; Spite M
Annu Rev Nutr; 2012 Aug; 32():203-27. PubMed ID: 22404117
[TBL] [Abstract][Full Text] [Related]
15. The Role of Resolvins: EPA and DHA Derivatives Can Be Useful in the Prevention and Treatment of Ischemic Stroke.
Tułowiecka N; Kotlęga D; Prowans P; Szczuko M
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33076354
[TBL] [Abstract][Full Text] [Related]
16. Lipoxins and new lipid mediators in the resolution of inflammation.
Schwab JM; Serhan CN
Curr Opin Pharmacol; 2006 Aug; 6(4):414-20. PubMed ID: 16750421
[TBL] [Abstract][Full Text] [Related]
17. Resolvins as proresolving inflammatory mediators in cardiovascular disease.
Capó X; Martorell M; Busquets-Cortés C; Tejada S; Tur JA; Pons A; Sureda A
Eur J Med Chem; 2018 Jun; 153():123-130. PubMed ID: 28732558
[TBL] [Abstract][Full Text] [Related]
18. Omega-3 PUFA derived anti-inflammatory lipid mediator resolvin E1.
Seki H; Tani Y; Arita M
Prostaglandins Other Lipid Mediat; 2009 Sep; 89(3-4):126-30. PubMed ID: 19737659
[TBL] [Abstract][Full Text] [Related]
19. Eicosapentaenoic and docosahexaenoic acid derived specialised pro-resolving mediators: Concentrations in humans and the effects of age, sex, disease and increased omega-3 fatty acid intake.
Calder PC
Biochimie; 2020 Nov; 178():105-123. PubMed ID: 32860894
[TBL] [Abstract][Full Text] [Related]
20. Roles of resolvins in the resolution of acute inflammation.
Qu Q; Xuan W; Fan GH
Cell Biol Int; 2015 Jan; 39(1):3-22. PubMed ID: 25052386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
